Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJQ51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,363
Award facts
- Contract value 100% obligated
- $30,362.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $30,362.68 by the Defense Logistics Agency on August 25, 2025, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for ultimate completion by August 26, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support mechanism.
This delivery order supports the Defense Logistics Agency's Medical Supply Chain by providing Otezla, a pharmaceutical treatment primarily indicated for psoriasis and psoriatic arthritis, to serve military healthcare programs and veteran systems. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The firm fixed-price structure and rapid completion timeline reflect the Defense Logistics Agency's operational efficiency in managing pharmaceutical inventories for military and federal health services.
Quick answers
Who was awarded contract SPE2DB25FJQ51?
SPE2DB25FJQ51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FJQ51 worth?
The government has obligated $30,363 on SPE2DB25FJQ51.
Is contract SPE2DB25FJQ51 an order under another contract?
Yes. SPE2DB25FJQ51 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJQ51 competed?
The extent of competition for SPE2DB25FJQ51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award